Fiche centre
Investigational Site Number : 3440001
Shatin, NT — Hong Kong
Essais liés2clinical trials
VilleShatin, NTlocalisation
PaysHong Konglocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06372145
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Tolebrutinib | SEP | Phase 3 | NCT04410978 | Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1) | COMPLETED |
| Tolebrutinib | SEP | Phase 3 | NCT06372145 | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. | ACTIVE_NOT_RECRUITING |